Germana Lissidini

Germana Lissidini

Auto-generated profile, based on publicly available information

Germana Lissidini

European Institute of Oncology, IRCCS

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
GFGabriel Farante
Gabriel Farante
ATAntonio Toesca
Antonio Toesca
FRANCESCA MAGNONIFRANCESCA MAGNONI
FRANCESCA MAGNONI
GLGermana Lissidini
Germana Lissidini
JVJosé Vila
José Vila
PVPAOLO VERONESI
PAOLO VERONESI

1 September 2015 in International Journal of Surgery
Verified
Journal Article
Closed access
GLGermana Lissidini
Germana Lissidini
FPFrancesco Prete
Francesco Prete
GPGiuseppe Piccinni
Giuseppe Piccinni
AGAngela Gurrado
Angela Gurrado
SGSimone Giungato
Simone Giungato
MTMARIO TESTINI
MARIO TESTINI
Emergency pancreaticoduodenectomy (EPD) has been very rarely reported in literature as a lifesaving procedure for complex pancreatic injury, uncontrollable hemorrhage from ulcers and tumors, descending duodenal perforations, and severe infection. The aim of this study was to analyze the experience of two non-trauma centers and to review the literature concerning emergency pancreaticoduodenectomy. From January 2005 to December 2014, from a population of 169 PD (92 females and 77 males; mean age: 61.3, range 23-81) 5 patients (3%; 2 females and 3 males; mean age: 57.8, range: 42-74) underwent EPD for non-traumatic disease performed at two Academic Units of the University of Bari. The emergency pancreaticoduodenectomy subgroup of patients showed an overall morbidity of 80%, and mortality of 40%. In 80% (4/5) of patients treated by emergency pancreaticoduodenectomy, the pancreatic remnant was not reconstructed, and in 20% (1/5) a pancreaticojejunostomy was performed. Emergency pancreaticoduodenectomy is an effective life-saving operation reservable to pancreatoduodenal trauma, perforations, and bleeding, unmanageable by a less invasive approach. It should be preferentially approached by surgeons with a high level of experience in hepatobiliary and pancreatic surgery and in trauma centers too, but it should also be in the armamentarium of general surgeons performing hepato-pancreato-biliary surgery.

11 April 2012 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
MTMARIO TESTINI
MARIO TESTINI
FLFrancesco Logoluso
Francesco Logoluso
GLGermana Lissidini
Germana Lissidini
AGAngela Gurrado
Angela Gurrado
GCGiuseppe Campobasso
Giuseppe Campobasso
GPGiuseppe Piccinni
Giuseppe Piccinni
Background: Acute respiratory failure due to thyroid compression or invasion of the tracheal lumen is a surgical emergency requiring urgent management. The aim of this paper is to describe a series of six patients treated successfully in the emergency setting with total thyroidectomy due to ingravescent dyspnoea and asphyxia, as well as review related data reported in literature.Methods: During 2005-2010, of 919 patients treated by total thyroidectomy at our Academic Hospital, 6 (0.7%; 4 females and 2 men, mean age: 68.7 years, range 42-81 years) were treated in emergency. All the emergency operations were performed for life-threatening respiratory distress. The clinical picture at admission, clinical features, type of surgery, outcomes and complications are described. Mean duration of surgery was 146 minutes (range: 53-260).Results: In 3/6 (50%) a manubriotomy was necessary due to the extension of the mass into the upper mediastinum. In all cases total thyroidectomy was performed. In one case (16.7%) a parathyroid gland transplantation and in another one (16.7%) a tracheotomy was necessary due to a condition of tracheomalacia. Mean post-operative hospital stay was 6.5 days (range: 2-10 days). Histology revealed malignancy in 4/6 cases (66.7%), showing 3 primitive, and 1 secondary tumors. Morbidity consisted of 1 transient recurrent laryngeal palsy, 3 transient postoperative hypoparathyroidism, and 4 pleural effusions, treated by medical therapy in 3 and by drains in one. There was no mortality.Conclusion: On the basis of our experience and of literature review, we strongly advocate elective surgery for patients with thyroid disease at the first signs of tracheal compression. When an acute airway distress appears, an emergency life-threatening total thyroidectomy is recommended in a high-volume centre.

9 April 2011 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Oreste D. GentiliniOreste D. Gentilini
Oreste D. Gentilini
PVPAOLO VERONESI
PAOLO VERONESI
EBEdoardo Botteri
Edoardo Botteri
FSFiammetta Soggiu
Fiammetta Soggiu
GTGiuseppe Trifirò
Giuseppe Trifirò
ALAlberto Luini
Alberto Luini

19 June 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
Luca NicosiaLuca Nicosia
Luca Nicosia
ALAntuono Latronico
Antuono Latronico
FAFrancesca Addante
Francesca Addante
RSRossella De Santis
Rossella De Santis
ABAnna Carla Bozzini
Anna Carla Bozzini
ECEnrico Cassano
Enrico Cassano
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal hyperplasia (ADH) to in situ or invasive carcinoma in patients who underwent vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. (2) Methods: 2955 VABBs were reviewed; 141 patients with a diagnosis of ADH were selected for subsequent surgical excision. The association between patients’ characteristics and the upgrade rate to breast cancer was evaluated in both univariate and multivariate analyses. (3) Results: the upgrade rates to ductal carcinoma in situ (DCIS) and invasive carcinoma (IC) were, respectively, 29.1% and 7.8%. The pooled upgrade rate to DCIS or IC was statistically lower at univariate analysis, considering the following parameters: complete removal of the lesion (p-value < 0.001); BIRADS ≤ 4a (p-value < 0.001); size of the lesion ≤15 mm (p-value: 0.002); age of the patients <50 years (p-value: 0.035). (4) Conclusions: the overall upgrade rate of ADH to DCIS or IC is high and, as already known, surgery should be recommended. However, ADH cases should always be discussed in multidisciplinary meetings: some parameters appear to be related to a lower upgrade rate. Patients presenting these parameters could be strictly followed up to avoid overtreatment.

12 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Luca NicosiaLuca Nicosia
Luca Nicosia
ABAnna Carla Bozzini
Anna Carla Bozzini
SPSilvia Penco
Silvia Penco
CTChiara Trentin
Chiara Trentin
MPMaria Pizzamiglio
Maria Pizzamiglio
Filippo PesapaneFilippo Pesapane
Filippo Pesapane
Background: We aimed to create a model of radiological and pathological criteria able to predict the upgrade rate of low-grade ductal carcinoma in situ (DCIS) to invasive carcinoma, in patients undergoing vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. Methods: A total of 3100 VABBs were retrospectively reviewed, among which we reported 295 low-grade DCIS who subsequently underwent surgery. The association between patients’ features and the upgrade rate to invasive breast cancer (IBC) was evaluated by univariate and multivariate analysis. Finally, we developed a nomogram for predicting the upstage at surgery, according to the multivariate logistic regression model. Results: The overall upgrade rate to invasive carcinoma was 10.8%. At univariate analysis, the risk of upgrade was significantly lower in patients with greater age (p = 0.018), without post-biopsy residual lesion (p < 0.001), with a smaller post-biopsy residual lesion size (p < 0.001), and in the presence of low-grade DCIS only in specimens with microcalcifications (p = 0.002). According to the final multivariable model, the predicted probability of upstage at surgery was lower than 2% in 58 patients; among these 58 patients, only one (1.7%) upstage was observed, showing a good calibration of the model. Conclusions: An easy-to-use nomogram for predicting the upstage at surgery based on radiological and pathological criteria is able to identify patients with low-grade carcinoma in situ with low risk of upstaging to infiltrating carcinomas.